Home - Products - Others - Other Targets - 6-(4-Hydroxy-3-methylphenyl)-2-methylhept-2-en-4-one

6-(4-Hydroxy-3-methylphenyl)-2-methylhept-2-en-4-one

CAS No. 949081-05-4

6-(4-Hydroxy-3-methylphenyl)-2-methylhept-2-en-4-one( —— )

Catalog No. M31564 CAS No. 949081-05-4

6-(4-Hydroxy-3-methylphenyl)-2-methylhept-2-en-4-one is a natural product for research related to life sciences.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 1782 In Stock
50MG Get Quote In Stock
100MG Get Quote In Stock

Biological Information

  • Product Name
    6-(4-Hydroxy-3-methylphenyl)-2-methylhept-2-en-4-one
  • Note
    Research use only, not for human use.
  • Brief Description
    6-(4-Hydroxy-3-methylphenyl)-2-methylhept-2-en-4-one is a natural product for research related to life sciences.
  • Description
    6-(4-Hydroxy-3-methylphenyl)-2-methylhept-2-en-4-one is a natural product for research related to life sciences.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Others
  • Target
    Other Targets
  • Recptor
    ——
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    949081-05-4
  • Formula Weight
    232.32
  • Molecular Formula
    C15H20O2
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    ——
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • 2-Acetamidophenyl 5-...

    phosphodiesterase 7 inhibitor.

  • Azetidine-2-carboxyl...

    Azetidine-2-carboxylic acid is a non proteinogenic amino acid homologue of proline found in common beets. Azetidine-2-carboxylic acid can be misincorporated into proteins in place of proline in many species including humans. It is a toxic and teratogenic agent.

  • Roemerine

    Roemerine is a potential active xanthine oxidase(XOD) inhibitor, XOD is a key enzyme in the pathogenesis of hyperuricemia and also a well-known target for the drug development to treat gout.